Biontech plans to produce mRNA vaccines in Africa
In an attempt to address covid-19 and a number of other widespread diseases in Africa, Biontech plans to establish a factory there for the production of mRNA vaccines.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Biontech plans to expand its production to Africa by establishing an mRNA vaccine factory to combat widespread diseases including covid-19.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Three global giants consider vaccine production in Denmark
For subscribers
EU demands Astrazeneca court order to supply vaccine doses
For subscribers
